(220315) -- HARBIN, March 15, 2022 -- A medical staff conducts a nucleic acid test on a man at a COVID-19 testing site in Harbin, northeast China s Heilongjiang Province, March 15, 2022. Harbin announced on Monday that enclosed public spaces should be temporarily closed. Anti-epidemic measures also include suspending cultural activities, night market, exhibitions and mass gatherings. ) CHINA-HEILONGJIANG-HARBIN-COVID-19 (CN) XiexJianfei

(220315) -- HARBIN, March 15, 2022 -- A medical staff conducts a nucleic acid test on a man at a COVID-19 testing site in Harbin, northeast China s Heilongjiang Province, March 15, 2022. Harbin announced on Monday that enclosed public spaces should be temporarily closed. Anti-epidemic measures also include suspending cultural activities, night market, exhibitions and mass gatherings. ) CHINA-HEILONGJIANG-HARBIN-COVID-19 (CN) XiexJianfei

Choose your license

Rights Managed:

One-time editorial use in an online article, social media channels, internal presentation, website, newsletter, or blog.

One-time editorial use in a book, newspaper or magazine (excluding cover page), external presentation. Limited to 5,000 circulation. This includes the rights available in the Standard license.

Media Info

Credit: Xinhua

Media ID:

Recording Date: Mar 15, 2022

Media Size: 4,928×3,280 Pixels

(220315) -- HARBIN, March 15, 2022 -- A medical staff conducts a nucleic acid test on a man at a COVID-19 testing site in Harbin, northeast China s Heilongjiang Province, March 15, 2022. Harbin announced on Monday that enclosed public spaces should be temporarily closed. Anti-epidemic measures also include suspending cultural activities, night market, exhibitions and mass gatherings. ) CHINA-HEILONGJIANG-HARBIN-COVID-19 (CN) XiexJianfei

Restrictions: This image can not be published in China.

Release Info: Do I need a release?

Captions may have been translated or enriched by an AI system.
For more information about AI-assisted captions, see AI-assisted captions.

Need a custom license?

If your intended use isn't covered by the available options (such as non-editorial purposes or specific distribution needs), contact us. Our team will be happy to provide a tailored offer based on your requirements.